Ledger.Open graph →
SEC Form D · Amendment · filed February 17, 2015

EIGER BIOPHARMACEUTICALS INC

Offering
$9.0M
Sold
$8.7M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Santa Clara, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Ed Engleman · Santa Clara, CADirectorJeffrey Glenn · Santa Clara, CADirectorDavid Cory · Santa Clara, CAExec · DirectorNina Kjellson · Santa Clara, CADirectorJacob Freifeld · Palo Alto, CADirectorSridhar Bearelly · New York, NYExec · DirectorDavid Deutsch · New York, NYDirectorTracy Overath · Austin, TXDirectorStuart Griffiths · Grand Cayman, Cayman IslandsExec · DirectorJason Vickers · Grand Cayman, Cayman IslandsDirectorJesper Poulsen · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗